Pay in 4 interest-free payments of $7.12 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
CJC-1295 (with DAC) is a modified GHRH analogue with an extended half-life achieved via Drug Affinity Complex (DAC) technology that covalently binds to serum albumin
Studies suggest that IBS patients often exhibit dysbiosis, with an imbalance in microbial diversity and shifts in the abundance of certain bacteria
Start with MOTS-c alone at target dose for 1014 days, establish baseline response (measure fasting glucose, insulin sensitivity markers, and body composition changes), then introduce 5-Amino-1MQ at starting dose and titrate upward while monitoring
It is widely studied in pre-clinical research for its effects on growth factor signalling, angiogenesis, and collagen synthesis
US$ 25.29
US$ 26.34
US$ 25.55
US$ 25.03
